Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer’s Disease
TAINAN, June 13, 2025 /PRNewswire/ -- Merry Life Biomedical Company announces the…
Creative Tech Textile’s Seawool Opens New Horizons for Sustainable Fashion
For World Environment Day, the company is sharing how material innovation can…